Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for infundibulocystic basal cell carcinoma has been reported in the published literature.
No clinical trials have been registered for infundibulocystic basal cell carcinoma.
6 publications have been identified in PubMed for infundibulocystic basal cell carcinoma. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Boujguenna I (2026). [PMID: 41878609](https://pubmed.ncbi.nlm.nih.gov/41878609/). *Oxf Med Case Reports*. [Case Report / Case Series]
Dana IN (2026). [PMID: 41772753](https://pubmed.ncbi.nlm.nih.gov/41772753/). *Australas J Dermatol*. [Diagnostic / Biomarker]
Pascolini G (2026). [PMID: 41645688](https://pubmed.ncbi.nlm.nih.gov/41645688/). *Dermatol Reports*. [Case Report / Case Series]
Hamada M (2025). [PMID: 39158191](https://pubmed.ncbi.nlm.nih.gov/39158191/). *J Dermatol*. [Case Report / Case Series]
van Dal M (2024). [PMID: 39276021](https://pubmed.ncbi.nlm.nih.gov/39276021/). *J Cutan Pathol*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center